Ryan Reddinger

Ryan Reddinger, Ph.D., is a Principal Scientist and Global Biomarker Lead at Amgen, where they focus on innovative drug development. They completed a Ph.D. in Microbiology and Immunology at the State University of New York at Buffalo, where their graduate research centered on the development of secondary bacterial pneumonia following influenza virus infections. Ryan's previous roles include postdoctoral research at the Walter Reed Army Institute of Research and positions at REGENXBIO Inc. and MIMETAS. Their work has significantly contributed to advancements in understanding bacterial infections and developing therapeutic strategies.